By Erin Fuchs ( December 15, 2009, 2:05 PM EST) -- A group of employee benefit plans has moved to certify a class of plaintiffs that paid or reimbursed for Wellbutrin XL, in an action accusing Biovail Corp. and GlaxoSmithKline PLC of suppressing the market for a generic version of the blockbuster antidepressant....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.